Share-based Payment Arrangement, Expense of MAIA Biotechnology, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MAIA Biotechnology, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • MAIA Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $646,900, a 42% increase year-over-year.
  • MAIA Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,514,299, a 2.6% decline year-over-year.
  • MAIA Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,912,744, a 38% decline from 2023.
  • MAIA Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,089,303, a 33% increase from 2022.
  • MAIA Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2,319,427, a 15% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MAIA Biotechnology, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,514,299 $646,900 +$191,512 +42% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,322,787 $802,484 +$388,536 +94% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,934,251 $371,472 +$21,507 +6.1% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $1,912,744 $693,443 -$668,490 -49% 01 Oct 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q3 2024 $2,581,234 $455,388 -$115,528 -20% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $2,696,762 $413,948 -$204,984 -33% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $2,901,746 $349,965 -$187,557 -35% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $3,089,303 $1,361,933 +$873,042 +179% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $2,216,261 $570,916 +$38,478 +7.2% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $2,177,783 $618,932 +$34,164 +5.8% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $2,143,619 $537,522 -$175,808 -25% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $2,319,427 $488,891 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $532,438 -$246,106 -32% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $584,768 -$192,364 -25% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $713,330 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q3 2021 $778,544 01 Jul 2021 30 Sep 2021 10-Q/A 06 Feb 2023 2022 Q3
Q2 2021 $777,132 01 Apr 2021 30 Jun 2021 10-Q 22 Aug 2022 2022 Q2

MAIA Biotechnology, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,912,744 -$1,176,559 -38% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
2023 $3,089,303 +$769,876 +33% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
2022 $2,319,427 -$403,466 -15% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $2,722,893 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.